Mike van Beek

448 total citations
15 papers, 342 citations indexed

About

Mike van Beek is a scholar working on Oncology, Cancer Research and Hematology. According to data from OpenAlex, Mike van Beek has authored 15 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Cancer Research and 4 papers in Hematology. Recurrent topics in Mike van Beek's work include Global Cancer Incidence and Screening (6 papers), Breast Cancer Treatment Studies (4 papers) and Colorectal Cancer Screening and Detection (3 papers). Mike van Beek is often cited by papers focused on Global Cancer Incidence and Screening (6 papers), Breast Cancer Treatment Studies (4 papers) and Colorectal Cancer Screening and Detection (3 papers). Mike van Beek collaborates with scholars based in Netherlands, United States and Canada. Mike van Beek's co-authors include Lucien E. M. Duijm, Johanna H. Groenewoud, Harry J. de Koning, Frits H. Jansen, Jacques Fracheboud, Jack B. Bishop, James W. Allen, John W. Breneman, Andrew J. Wyrobek and Xiu Lowe and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Mike van Beek

15 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike van Beek Netherlands	12	139	113	84	68	58	15	342
LFAG Massuger Netherlands	6	113 0.8×	126 1.1×	162 1.9×	151 2.2×	18 0.3×	9	457
Zhimin Shao China	12	112 0.8×	187 1.7×	26 0.3×	94 1.4×	45 0.8×	23	362
Woo-Chul Noh South Korea	8	86 0.6×	173 1.5×	117 1.4×	140 2.1×	42 0.7×	18	383
S A Bartow United States	7	166 1.2×	106 0.9×	181 2.2×	62 0.9×	13 0.2×	8	416
Kandice K. Ludwig United States	10	144 1.0×	197 1.7×	135 1.6×	176 2.6×	12 0.2×	36	465
Héctor Tobón United States	17	93 0.7×	101 0.9×	46 0.5×	126 1.9×	18 0.3×	19	616
Viola Liberale Italy	9	65 0.5×	128 1.1×	52 0.6×	101 1.5×	12 0.2×	19	346
Satoru Munakata Japan	12	103 0.7×	110 1.0×	19 0.2×	97 1.4×	10 0.2×	47	458
Marit Valla Norway	10	103 0.7×	103 0.9×	39 0.5×	36 0.5×	23 0.4×	23	307
James G. Kuhns United States	11	115 0.8×	82 0.7×	47 0.6×	67 1.0×	34 0.6×	18	346

Countries citing papers authored by Mike van Beek

Since Specialization

Citations

This map shows the geographic impact of Mike van Beek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike van Beek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike van Beek more than expected).

Fields of papers citing papers by Mike van Beek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike van Beek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike van Beek. The network helps show where Mike van Beek may publish in the future.

Co-authorship network of co-authors of Mike van Beek

This figure shows the co-authorship network connecting the top 25 collaborators of Mike van Beek. A scholar is included among the top collaborators of Mike van Beek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike van Beek. Mike van Beek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mané-Damas, Marina, Abhishek Saxena, Gisela Nogales‐Gadea, et al.. (2025). Efficacy of MLN9708 (ixazomib) in experimental autoimmune myasthenia gravis and in anti-AChR producing primary thymic cell cultures from myasthenia gravis patients. Frontiers in Immunology. 16. 1521432–1521432. 1 indexed citations

Broek, Alexandra J. van den, Laura van ‘t Veer, Maartje J. Hooning, et al.. (2015). Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers. Journal of Clinical Oncology. 34(5). 409–418. 63 indexed citations

Nederend, Joost, Adri C. Voogd, J.W.W. Coebergh, et al.. (2013). Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands. British Journal of Cancer. 109(1). 242–248. 15 indexed citations

Duijm, Lucien E. M., Johanna H. Groenewoud, Marieke W.J. Louwman, et al.. (2011). Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study. Breast Cancer Research and Treatment. 129(3). 955–961. 12 indexed citations

Duijm, Lucien E. M., Adri C. Voogd, Johanna H. Groenewoud, et al.. (2011). Lower sensitivity of screening mammography after previous benign breast surgery. International Journal of Cancer. 130(1). 122–128. 12 indexed citations

Schaper, Nicolaas C., et al.. (2010). Primary squamous cell carcinoma of the thyroid years after radioactive iodine treatment.. PubMed. 68(5). 224–6. 6 indexed citations

Duijm, Lucien E. M., Johanna H. Groenewoud, Jacques Fracheboud, et al.. (2008). Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000–2005. European Radiology. 18(11). 2390–2397. 14 indexed citations

Duijm, Lucien E. M., Johanna H. Groenewoud, Harry J. de Koning, et al.. (2008). Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography. European Journal of Cancer. 45(5). 774–781. 39 indexed citations

Everts, Peter A., J. J. Jakimowicz, Mike van Beek, et al.. (2007). Reviewing the Structural Features of Autologous Platelet-Leukocyte Gel and Suggestions for Use in Surgery. European Surgical Research. 39(4). 199–207. 27 indexed citations

10.

Duijm, Lucien E. M., Johanna H. Groenewoud, Frits H. Jansen, et al.. (2004). Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening. British Journal of Cancer. 91(10). 1795–1799. 60 indexed citations

11.

Guelen, Ilja, et al.. (2004). RECONSTRUCTION OF RADIAL ARTERY PRESSURE FROM NON-INVASIVE FINGER ARTERIAL PRESSURE MEASUREMENTS IN PATIENTS WITH ISCHEMIC HEART DISEASE. Journal of Hypertension. 22(Suppl. 2). S280–S281. 1 indexed citations

12.

Lowe, Xiu, B. W. Collins, James W. Allen, et al.. (1995). Aneuploidies and micronuclei in the germ cells of male mice of advanced age. Mutation Research/DNAging. 338(1-6). 59–76. 59 indexed citations

13.

Reichert, L. J. M., et al.. (1992). Lymph node histology simulating T-cell lymphoma in adult-onset Still's disease. Annals of Hematology. 65(1). 53–54. 11 indexed citations

14.

Vleugels, M.P.H., Hans A.M. Brölmann, & Mike van Beek. (1990). Primary Melanoma of the Cervix Uteri, an Avis Rara? A Review of the Literature. Acta Obstetricia Et Gynecologica Scandinavica. 69(3). 259–264. 11 indexed citations

15.

Bär, Brigitte, et al.. (1986). Primary Malignant Lymphoma of the Uterine Cervix Associated with Cold-Reacting Autoantibody-Mediated Hemolytic Anemia. Acta Haematologica. 75(4). 232–235. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact